Related Experiment Video

Updated: Jun 11, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 10, 2014

Anti-HIV drugs for cancer therapeutics: back to the future?

Warren A Chow1, Chunling Jiang, Min Guan

  • 1Beckman Research Institute of the City of Hope, Division of Medical Oncology, Department of Clinical and Molecular Pharmacology, Duarte, CA USA.

The Lancet. Oncology
|December 30, 2008
PubMed

Insights

Anti-HIV drugs, particularly HIV protease inhibitors, show promise as anticancer agents. These drugs exhibit multiple antitumour effects beyond immune reconstitution, offering a new class of cancer therapeutics.

Area of Science:

  • Oncology
  • Virology
  • Pharmacology

Background:

  • Anti-HIV drugs have been explored for cancer treatment, with early attempts like Azidothymidine showing limited success.
  • Highly Active Antiretroviral Therapy (HAART) has transformed HIV management and revealed potential anticancer properties of its components.

Purpose of the Study:

  • To investigate the antitumour properties of anti-HIV drugs, specifically HIV protease inhibitors.
  • To explore the mechanisms behind the anticancer effects of these agents beyond their impact on HIV.

Main Methods:

  • Review of existing studies on anti-HIV drugs (e.g., Azidothymidine, HIV protease inhibitors) in cancer treatment.
  • Analysis of clinical data for HAART in HIV-related Kaposi's sarcoma and other malignancies.
  • Examination of the pleiotropic antitumour effects attributed to HIV protease inhibitors.

Main Results:

  • HIV protease inhibitors demonstrate efficacy against various solid and haematological malignancies, not solely HIV-related Kaposi's sarcoma.
  • Anticancer effects are observed independently of immune reconstitution in some cases.
  • Mechanisms include inhibition of angiogenesis, inflammation, proteasome activity, proliferation, and induction of apoptosis.

Conclusions:

  • HIV protease inhibitors represent a novel class of anticancer drugs with diverse mechanisms of action.
  • Further research into anti-HIV drugs may yield additional promising cancer therapeutics.

More Related Videos

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...